A Study on Emotional Intelligence at Health Care Industry

As my last post on the Drug eluting stent (DES) system, I have found one more innovative use of the stent system, which provides continues immunosuppresssant effect.

With the approval date of Feb 1, 2008 from US-FDA Endeavorâ Zotarolimus Eluting Coronary stent is introduced in the market. A novel idea is used to provide effect of an Immunosuppressant drug through the coronary stent system.